FDA Investigator Edwin Martinez
Edwin Martinez has inspections in 4 countries as of 20 Sep 2023. Edwin Martinez has collaborated with a combined 2596 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
India,
China
Co-Investigator(s):
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Alan P Kurtzberg,
Alberto A Viciedo,
Anita Narula, PhD,
Ann L Demarco,
Annette Melendez,
Anthony A Charity,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arsen Karapetyan,
Barbara Janine Breithaupt,
Bonita S Chester,
Brenda Rivera,
Carla A Norris,
Carlos A Medina,
CDR Ileana Barreto Pettit,
CDR Thomas R Berry, PPh,
Charles I Ann,
Charles M Edwards,
Chelsea N Sealey,
Cheryl A Clausen,
Christina A Miller,
Claire M Minden,
Dana M Klimavicz,
Dayna I Martinez,
Dewayne E Whitlock,
Djamila Harouaka,
Eric S Weilage,
Felix Maldonado,
Frances L Dejesus,
Gam S Zamil,
German Rivera,
Gwyn G Dickinson,
Hector J Colon Torres,
Iraida Ortiz,
Israel Santiago, OCM,
Ivis L Negron,
Ivis Lnegron Torres,
James C Maclaughlin,
James S Cartwright,
Jason F Chancey,
Javier O Vega,
Jeffrey P Raimondi,
Jennifer A Quinones,
Jogy George,
John A Gonzalez,
Jorge E Martinez,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Cruz,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose Lpez,
Jose M Cayuela,
Jose Perez Soto,
Jose R Lopez,
Jose Velez,
Juan Rjimenez Garcia,
Karl D Hezel,
Kent C Faul,
Krishna Ghosh, PhD,
Laiza V Garcia,
Lareese K Thomas,
Lata C Mathew, PhD,
Laura E Garcia,
Lauren N Howard,
Laurimer Kuilan Torres,
Libia M Lugo,
Lisa M Lopez,
Lourdes Andujar,
LT Rafael Gonzalez,
Luis Soto Lopez,
Marian E Ramirez,
Marianela Aponte,
Marianela Aponte Cruz,
Marijo B Kambere, PhD,
Marlene Rodriguez Colon,
Martin K Yan, PhD,
Martin Yan,
Mary E Storch,
Michael R Goga,
Michael R Klapal,
Michelle Y Clark Stuart,
Miguel A Martinez,
Miguel Hernandez Sanchez,
Milva E Melendez,
Min Tang,
Minerva Rogers,
Muralidhara B Gavini, PhD,
Myriam M Sosa,
Nancy Rosado,
Nebil A Oumer,
Nicole E Knowlton,
Nilufer M Tampal, PhD,
Nilufer M Tampalm, PhD,
Noreen Muniz,
Pablo Feliciano,
Patrick C Klotzbuecher,
Patrick L Wisor,
Peter E Baker,
Pratik S Upadhyay, DDC,
Rafael E Cruz,
Rafael Nevarez,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Rapti D Madurawe,
Raquel Gonzalez,
Raquel Gonzalez Rivera,
Raymond T Oji,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Robert J Martin,
Rochelle L Cross,
Russell K Riley,
Santos E Camara,
Sarah E Mcmullen,
Sarah Forney,
Sixto M Mercado Rios,
Sonia M Monges,
Sony Mathews,
Sriram Susrambraham,
State Agency,
Stephen J Mottola,
Steven B Barber,
Susan F Laska, MS,
Temar Q Williams,
Thomas J Arista,
Truong Xuan Nguyen (Andy),
Ucheabuchi C Chudi Nwankwor,
Victor S Pacheco,
Vilmary Negron Rodriguez,
Wanda J Torres,
Ying Zhang,
Yvette I Henry,
Yvette I Johnson,
Zhao Wang, PhD,
Zhongren Wu
Edwin Martinez's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2012 | FDA 483 | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe - Form 483, 2012-10-22 |
February, 2005 | EIR | McNeil Healthcare LLC. - EIR, 2005-02-23 |
April, 2002 | EIR | Wyeth Pharmaceuticals Company - EIR, 2002-04-04 |
November, 2002 | EIR | Neopharm Labs Inc. - EIR, 2005-03-25 |
April, 2002 | FDA 483 | Wyeth Pharmaceuticals Company - Form 483, 2002-04-04 |
September, 2007 | FDA 483 | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2007-09-07 |
March, 2017 | FDA 483 | Ex-Lax, Inc. - Form 483, 2017-03-31 |
February, 2005 | FDA 483 | McNeil Healthcare LLC. - Form 483, 2005-02-23 |
October, 2012 | EIR | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe - EIR, 2012-10-22 |
August, 2009 | FDA 483 | Agropharma Laboratories Inc. - Form 483, 2009-08-19 |
February, 2004 | EIR | Knoll LLC - EIR, 2004-02-06 |
February, 2004 | FDA 483 | Knoll LLC - Form 483, 2004-02-06 |
June, 2009 | FDA 483 | Wyeth Parenterals Divison of Wyeth Holdings Corp. - Form 483, 2009-06-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more